# Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)

> **NCT00103792** · PHASE3 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 84 (actual)

## Conditions studied

- Wegener's Granulomatosis
- Vasculitis

## Interventions

- **DRUG:** mycophenolate mofetil
- **DRUG:** cyclophosphamide

## Key facts

- **NCT ID:** NCT00103792
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-01
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00103792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00103792, "Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00103792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*